Improved Antibacterial Activity of 1,3,4-Oxadiazole-Based Compounds That Restrict <i>Staphylococcus aureus</i> Growth Independent of LtaS Function.

"The authors declare no competing financial interest."

"M.L. would like to acknowledge the Academy of Medical Sciences (SBF006/1023); M.L., S.D., and M.S. would like to acknowledge the GW4 Generator grant (GW4-GF2-015). S.D. acknowledges funding from the MRC Centre for Medical Mycology at the University of Exeter and the NIHR Exeter Biomedical Research Centre. Additional work may have been undertaken by the University of Exeter Biological Services Unit. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. M.L. and S.D. would like to acknowledge the Microbiology Society for funding and Conor Dazley for technical assistance. The authors would like to thank Prof. Angelika Gründling (Imperial College London), Prof. Dorte Frees (University of Copenhagen), and Prof. Chikara Kaito (Okayama University) for kindly providing strains used in this study. The authors thank AsedaSciences for conducting the SYSTEMETRIC cell health screen and Dr. Tobias Bergmiller, Dr. Remy Chait (University of Exeter), and Dr Jonathan Tyrrell (Swansea University) for helpful discussions."